1002 - Immunotherapy: ALLOGENEIC T-CELL IMMUNOTHERAPY (CE-VST01-JC) FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) USING A HLA-DEFINED PEPTIDE PLATFORM

Autor: Thomas, G. Ambalathingal, Smith, C., Best, S., Beagley, L., Panikkar, A., Porter, D., Khanna, R.
Zdroj: In Cytotherapy May 2023 25(6) Supplement:S211-S212
Databáze: ScienceDirect